* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *

GlaxoSmithKline

                   

Examine The CNS Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth...

marketwire.com
Oct 9, 2008 4 related
        

LONDON, UNITED KINGDOM--(Marketwire - Oct. 9, 2008) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. The CNS Market Outlook to 2013:...

add comment

Human Factors International: Scott Weiss of Human Factors International (HFI) discusses mobile...

tmcnet.com
Oct 9, 2008
        

Scott Weiss, Executive Director EMEA of Human Factors International (HFI), will share his insights into mobile design and development platforms with attendees at this year's Handsets Forum USA, which takes place 29 to 30...

add comment
                   

Canadian Vaccine Manufacturer Able to Deliver Doses Ahead of Schedule

pharmiweb.co.uk
Oct 9, 2008 1 related
        

From Canada Newswire English (October 9, 2008) MISSISSAUGA, ON, Oct. 9 /CNW/ - GlaxoSmithKline Inc. (GSK) today announced that it has begun shipment of FLUVIRAL(R) (Influenza Virus Vaccine) to Canadian private market customers...

add comment

GLANCE STOCKS NEWS EUROPE-Astra up in weak pharma after Citi support

finanznachrichten.de
Oct 9, 2008 3 related
        

STOCKS NEWS Reuters Results diary Stocks on the move Real-time Equity News 08:45GMT 09Oct2008-Astra up in weak pharma after Citi support AstraZeneca shares are up 1.8 percent after Citi raises share price target to 27 pounds...

add comment

Latest Advances in Drug Discovery & Development

chemeurope.com
Oct 9, 2008 2 related
        

13 Oct 2008 - 17 Oct 2008 Bryn Mawr, Philadelphia, United States of America - Program: Best Practices Virtual Screening Workshop; Docking & Scoring, chaired by Chaya Duraiswami (GlaxoSmithKline), Application of MM-PBSA Free...

add comment
                   

Streamlining Genmab Cuts 100 Jobs, Drops Pivotal CTCL Drug

tmcnet.com
Oct 8, 2008 4 related
        

Ofatumumab BLA Expected by Year-End Gearing up for potential commercialization of its lead program, ofatumumab, in chronic lymphocytic leukemia next year - and taking into account the current economic environment - Danish...

add comment
                   

Pfizer Rearranges the Deck Chairs (at Motley Fool)

yahoo.com
Oct 8, 2008 2 related
        

Here's a way to spin your wheels: Pfizer (NYSE: PFE) is realigning, but the changes won't result in any new job cuts. While those specialties will span Europe and the U.S., Pfizer isn't giving up its geographic focus...

add comment

Euro RSCG Wins Levitra's Creative - Adweek

micropersuasion.com
Oct 8, 2008 1 related
        

Euro RSCG Wins Levitra's CreativeAdweek, NY - 17 minutes agoEuro RSCG had no immediate comment, but a Schering-Plough representative confirmed the hire. The new agency succeeds Omnicom Group's BBDO here, ...

add comment
                   

Between the Lines of the Voluntary Ban on Cold Meds for Kids

drugpolicycentral.com
Oct 9, 2008
        

The way pseudoephedrine is now (due to the fact that itb s an ingredient in crystal meth). (Wed Oct 08 19:34:31 2008 PDT)[$drug_related(100%), $drugwar_propaganda(70%), $propaganda_theme2(60%), $propaganda_theme5(70%),...

add comment
                   

Is an Rx-to-OTC move the right prescription to protect pharma revenues and cut healthcare costs?

pharmiweb.co.uk
Oct 8, 2008
        

The growing cost of developing novel drugs, combined with the fact that fewer such drugs are gaining regulatory approval from year-to-year, is leading the cost-conscious pharmaceutical industry to make increasing use of...

add comment